Detalhe da pesquisa
1.
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma.
Future Oncol
; 18(17): 2041-2051, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272485
2.
Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments.
JCO Oncol Pract
; 20(1): 19-32, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963306
3.
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.
Cancers (Basel)
; 16(6)2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539485
4.
Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC).
Clin Lung Cancer
; 24(2): 120-129, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585341
5.
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor.
Invest New Drugs
; 30(3): 1261-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350804
6.
Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung.
Clin Lung Cancer
; 23(6): 457-466, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872084
7.
Treatment considerations for patients with advanced squamous cell carcinoma of the lung: a plain language summary.
Lung Cancer Manag
; 11(3): LMT56, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284556
8.
The role of proteasome inhibition in nonsmall cell lung cancer.
J Biomed Biotechnol
; 2011: 806506, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21629760
9.
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706885
10.
Treatment options after first-line immunotherapy in metastatic NSCLC.
Expert Rev Anticancer Ther
; 20(3): 221-228, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32141356
11.
Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of Afatinib.
Onco Targets Ther
; 13: 9305-9321, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061419
12.
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
J Clin Oncol
; 38(7): 753-766, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829901
13.
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
J Thorac Oncol
; 15(2): 274-287, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31655296
14.
Gene expression profiling and non-small-cell lung cancer: where are we now?
Clin Lung Cancer
; 10(3): 168-73, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19443336
15.
Second-line therapy for non-small-cell lung cancer.
Clin Lung Cancer
; 10(2): 91-8, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19362951
16.
How is gene-expression profiling going to challenge the future management of lung cancer?
Future Oncol
; 5(6): 827-35, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19663732
17.
Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network.
Cancer Res
; 79(3): 625-638, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563891
18.
Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy.
Cureus
; 10(9): e3371, 2018 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510881
19.
Challenges in Lung Cancer Screening in Latin America.
J Glob Oncol
; 4: 1-10, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30241252
20.
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
Oncol Ther
; 6(1): 45-58, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700141